This content is machine translated Hepatitis C Light at the end of the tunnel The introduction of interferon-free combination therapies with “direct acting antivirals” (DAA) was a breakthrough. Medically, therapy with current drugs can be recommended to all patients with active HCV infection. As…
View Post 4 min This content is machine translated 2nd Spring Congress of the SGAIM Viral hepatitides – how and whom to test? Hepatitis C is the “favorite child” of current medical ethics discussions. However, the new, expensive HCV drugs should not cloud the view of the overall diagnostic and therapeutic situation of…
View Post 4 min This content is machine translated Hepatocellular carcinoma Is tumor recurrence following hepatitis C therapy? The new direct-acting antiviral agents (DAAs) for the treatment of hepatitis C enable a cure in most cases. At the same time, the cost of such treatment is enormous and…
View Post 7 min This content is machine translated Hepatitis C Combating the epidemic with new knowledge More people die from hepatitis C than from HIV. Half of hepatitis C sufferers are unaware of their infection. Individuals born in the 1960s are at increased risk for hepatitis…
